Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga April 21, 2014 at 08:08 AM EDT Sarepta Therapeutics (NASDAQ: SRPT) soared 75.37% to $42.79 in the pre-market trading on announcement that it will file NDA for ... Read More >> Related Stocks: Astrazeneca Plc ADR Momenta Pharma Pfizer Sarepta Therapeutics